BioTechGrid

A recent groundbreaking study published in the esteemed journal Nature Medicine has emerged from the innovative research team at Karolinska…

Neumora Therapeutics’ big bet on a new era of neuroscience has delivered an age-old result. The first of three late-stage…

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading…

Dealmakers at BeiGene, Brii Biosciences and Ideaya Biosciences had a busy end to the year, sharing news of agreements for…

Cash-strapped Viracta Therapeutics is continuing to reduce its options in order to stay afloat. Less than two months after announcing…

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up…

The festive season may be a chance to rest up and recharge—but tell that to biotech dealmakers, who have been…

Roche is wasting no time in getting out its checkbook in 2025, signing a new biobucks-heavy pact that aims to…

In a significant breakthrough that could redefine thermal management systems, researchers from Hokkaido University have introduced a remarkable advancement in…

Ebola Virus Dynamics: New Insights into Infection and Transmission Pathways Ebola virus disease (EVD) has long been a subject of…